Molecular basis for the disease-modifying effects of belimumab in systemic lupus erythematosus and molecular predictors of early response: blood transcriptome analysis implicates the innate immunity and DNA damage response pathways

Belimumab treatment ameliorates multiple innate and adaptive immunity dysregulations of SLE and may reverse the disease signature, consistent with the drug effects on reducing activity and preventing flares. Fingerprints of innate immunity correlate with robust improvement whereas DNA damage response with less responsive disease to BAFF inhibition.

Authors

Institutions

Publication Details

Journal
Annals of the Rheumatic Diseases
Published
2024-11-07
DOI
https://doi.org/10.1136/ard-2024-226051
Citations
16
Primary Topic
Systemic Lupus Erythematosus Research
Type
article
Field-Weighted Citation Impact
7.52

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Molecular basis for the disease-modifying effects of belimumab in systemic lupus erythematosus and molecular predictors of early response: blood transcriptome analysis implicates the innate immunity and DNA damage response pathways

Panagiotis Garantziotis, George Sentis, Myrto Nikoloudaki, Anastasia Filia et al.
16 citations
Annals of the Rheumatic Diseases
Systemic Lupus Erythematosus Research
7.52
article

Molecular basis for the disease-modifying effects of belimumab in systemic lupus erythematosus and molecular predictors of early response: blood transcriptome analysis implicates the innate immunity and DNA damage response pathways

Panagiotis Garantziotis, George Sentis, Myrto Nikoloudaki, Anastasia Filia, Nikolaos Malissovas, Styliani Polia, Dimitrios T. Boumpas, George K Bertsias, Noemin Kapsala, Dionysis Nikolopoulos, Georgia-Savina Moysidou, Evgenia Stergioti, Nikolaos Paschalidis, Antonis Fanouriakis, Spyridon Katechis, Dimitra Nikoleri, Maria Grigoriou
article en
16 citations

Abstract

Belimumab treatment ameliorates multiple innate and adaptive immunity dysregulations of SLE and may reverse the disease signature, consistent with the drug effects on reducing activity and preventing flares. Fingerprints of innate immunity correlate with robust improvement whereas DNA damage response with less responsive disease to BAFF inhibition.

Annals of the Rheumatic DiseasesVol. 84(2)
University of Crete (GR), Democritus University of Thrace (GR), National and Kapodistrian University of Athens (GR), Academy of Athens (GR), Karolinska Institutet (SE), Universitätsklinikum Erlangen (DE), FORTH Institute of Molecular Biology and Biotechnology (GR), University Hospital of Alexandroupolis (GR)
GlaxoSmithKline, Deutsche Forschungsgemeinschaft, European Research Council
Good health and well-being
Openalex Percentile: Top 2%
Systemic Lupus Erythematosus Research
7.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.